SCHEMBL18197875

SCHEMBL18197875

CC(C)CCNC(=O)c1ccc(-c2ccc3nnc(Cc4ccc5c(c4)CCOC5)n3n2)s1

nearest known ligand 0.37

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MET P08581 18/20 0.37
EPHX2 P34913 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2499476 0.89 MET (0.46) MET
SCHEMBL14439068 0.78 MET (0.44) MET
SCHEMBL2493611 0.77 MET (0.43) MET
SCHEMBL2491763 0.72 MET (0.47) MET
SCHEMBL14465811 0.70 MET (0.43) MET
SCHEMBL14439111 0.70 MET (0.40) MET
SCHEMBL2495186 0.70 MET (0.46) MET
SCHEMBL2493071 0.70 MET (0.47) MET
SCHEMBL2497289 0.70 MET (0.52) MET
SCHEMBL19338434 0.68 HDAC1 (0.38) METEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966214-B1 TRIAZOLOPYRIDAZINES AS TYROSINE KINASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2016-11-02 EP disclosed